This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


Polycystic ovarian syndrome: New review to help diagnose and manage

Polycystic ovaries
Credit: Pixabay/CC0 Public Domain

A new review in CMAJ (Canadian Medical Association Journal) is aimed at helping clinicians diagnose and manage polycystic ovarian syndrome (PCOS), an endocrine disorder that affects about 10% of females.

This disorder affects females of reproductive age and is associated with infertility, miscarriage and pregnancy complications. Its long-term health consequences include hypertension, cancer risks, and metabolic and psychological impacts. Patients usually present to health care between ages 18 and 39 years complaining of menstrual cycle irregularities, acne and excessive hair growth, but diagnosis and treatment are often delayed.

The authors of the review hope it will raise awareness of PCOS and help clinicians diagnose and manage the disorder.

"Polycystic ovarian syndrome can be treated effectively, and can allow for close monitoring and preventive care," said lead author Dr. Ebernella Shirin Dason, a and infertility fellow at Sinai Health System, Toronto, Ontario.

Management of the condition may include support for , combined hormonal contraceptives and nonhormonal medication like metformin.

Though people with PCOS are more likely to be overweight or obese, the authors caution that "clinicians should be particularly sensitive to weight stigma as patients with PCOS are at risk of dysmorphic body image and disordered eating."

More information: Diagnosis and management of polycystic ovarian syndrome, Canadian Medical Association Journal (2024). DOI: 10.1503/cmaj.231251

Citation: Polycystic ovarian syndrome: New review to help diagnose and manage (2024, January 29) retrieved 25 April 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Treating polycystic ovary syndrome costs $8 billion a year in US alone


Feedback to editors